Heavy-ions beams offer several advantages compared to other radiation such as low lateral scattering and high biological effectiveness (RBE) in the Bragg peak region, making them particularly attractive for the treatment of radio-resistant tumours localized close to organs at risk [1]. The extension of ion therapy to new clinical cases requires the exploitation of a dedicated treatment planning system (TPS) based on the existing version of TRiP98 [2,3], established TPS for carbon ions. The theoretical models and experimental databases included in TRiP98 are presently mainly based on measurements in water. This approximation can be applied successfully to reproduce many biological tissues with the exception of bones, where the presenc...
PURPOSE: Proton therapy with Pencil Beam Scanning (PBS) has the potential to improve radiotherapy tr...
Background: In treatment planning of charged-particle therapy, tissue heterogeneity is conventionall...
Uncertainties in determining clinically used relative biological effectiveness (RBE) values for ion ...
Heavy-ions beams offer several advantages compared to other radiation such as low lateral scattering...
Background: In radiation therapy with ion beams, lateral distributions of absorbed dose in the tiss...
Radiotherapy with heavy ions, in particular, 12C beams, is one of the most advanced forms of cancer ...
Purpose:Using the carbon ion beam for range measurements instead of photons would avoid the uncertai...
We used the GEANT4 Monte Carlo MC Toolkit to simulate carbon ion beams incident on water, tissue, an...
In treatment planning of charged-particle therapy, tissue heterogeneity is conventionally modeled as...
Abstract Sharp dose gradients and high biological effectiveness make ions such as 12C an ideal tool ...
The dose uniformity and penumbra in the treatment field are important factors in radiotherapy, which...
<div><p>In particle radiotherapy, range uncertainty is an important issue that needs to be overcome....
Abstract: The goal of charged-particle therapy is to control the tumors while maintaining the normal...
Background: In treatment planning of charged-particle therapy, tissue heterogeneity is conventionall...
In particle radiotherapy, range uncertainty is an important issue that needs to be overcome. Because...
PURPOSE: Proton therapy with Pencil Beam Scanning (PBS) has the potential to improve radiotherapy tr...
Background: In treatment planning of charged-particle therapy, tissue heterogeneity is conventionall...
Uncertainties in determining clinically used relative biological effectiveness (RBE) values for ion ...
Heavy-ions beams offer several advantages compared to other radiation such as low lateral scattering...
Background: In radiation therapy with ion beams, lateral distributions of absorbed dose in the tiss...
Radiotherapy with heavy ions, in particular, 12C beams, is one of the most advanced forms of cancer ...
Purpose:Using the carbon ion beam for range measurements instead of photons would avoid the uncertai...
We used the GEANT4 Monte Carlo MC Toolkit to simulate carbon ion beams incident on water, tissue, an...
In treatment planning of charged-particle therapy, tissue heterogeneity is conventionally modeled as...
Abstract Sharp dose gradients and high biological effectiveness make ions such as 12C an ideal tool ...
The dose uniformity and penumbra in the treatment field are important factors in radiotherapy, which...
<div><p>In particle radiotherapy, range uncertainty is an important issue that needs to be overcome....
Abstract: The goal of charged-particle therapy is to control the tumors while maintaining the normal...
Background: In treatment planning of charged-particle therapy, tissue heterogeneity is conventionall...
In particle radiotherapy, range uncertainty is an important issue that needs to be overcome. Because...
PURPOSE: Proton therapy with Pencil Beam Scanning (PBS) has the potential to improve radiotherapy tr...
Background: In treatment planning of charged-particle therapy, tissue heterogeneity is conventionall...
Uncertainties in determining clinically used relative biological effectiveness (RBE) values for ion ...